These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 11251248)
1. Nanoparticulate systems for the delivery of antisense oligonucleotides. Lambert G; Fattal E; Couvreur P Adv Drug Deliv Rev; 2001 Mar; 47(1):99-112. PubMed ID: 11251248 [TBL] [Abstract][Full Text] [Related]
2. Polyisobutylcyanoacrylate nanocapsules containing an aqueous core for the delivery of oligonucleotides. Lambert G; Fattal E; Pinto-Alphandary H; Gulik A; Couvreur P Int J Pharm; 2001 Feb; 214(1-2):13-6. PubMed ID: 11282229 [TBL] [Abstract][Full Text] [Related]
3. Antisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated Ha-ras-mediated cell proliferation and tumorigenicity in nude mice. Schwab G; Chavany C; Duroux I; Goubin G; Lebeau J; Hélène C; Saison-Behmoaras T Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10460-4. PubMed ID: 7937975 [TBL] [Abstract][Full Text] [Related]
4. An approach for new anticancer drugs: oncogene-targeted antisense DNA. Schwab G; Duroux I; Chavany C; Hélène C; Saison-Behmoaras E Ann Oncol; 1994; 5 Suppl 4():55-8. PubMed ID: 8060898 [TBL] [Abstract][Full Text] [Related]
5. An antisense oligonucleotide carrier based on amino silica nanoparticles for antisense inhibition of cancer cells. Peng J; He X; Wang K; Tan W; Li H; Xing X; Wang Y Nanomedicine; 2006 Jun; 2(2):113-20. PubMed ID: 17292123 [TBL] [Abstract][Full Text] [Related]
6. On the in vitro and in vivo properties of four locked nucleic acid nucleotides incorporated into an anti-H-Ras antisense oligonucleotide. Fluiter K; Frieden M; Vreijling J; Rosenbohm C; De Wissel MB; Christensen SM; Koch T; Ørum H; Baas F Chembiochem; 2005 Jun; 6(6):1104-9. PubMed ID: 15861430 [TBL] [Abstract][Full Text] [Related]
7. Cationic polyhexylcyanoacrylate nanoparticles as carriers for antisense oligonucleotides. Zobel HP; Kreuter J; Werner D; Noe CR; Kümel G; Zimmer A Antisense Nucleic Acid Drug Dev; 1997 Oct; 7(5):483-93. PubMed ID: 9361907 [TBL] [Abstract][Full Text] [Related]
8. Site-specific administration of antisense oligonucleotides using biodegradable polymer microspheres provides sustained delivery and improved subcellular biodistribution in the neostriatum of the rat brain. Khan A; Sommer W; Fuxe K; Akhtar S J Drug Target; 2000; 8(5):319-34. PubMed ID: 11328659 [TBL] [Abstract][Full Text] [Related]
9. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides. Hussain M; Shchepinov M; Sohail M; Benter IF; Hollins AJ; Southern EM; Akhtar S J Control Release; 2004 Sep; 99(1):139-55. PubMed ID: 15342187 [TBL] [Abstract][Full Text] [Related]
10. State of the art and perspectives for the delivery of antisense oligonucleotides and siRNA by polymeric nanocarriers. Fattal E; Bochot A Int J Pharm; 2008 Dec; 364(2):237-48. PubMed ID: 18619528 [TBL] [Abstract][Full Text] [Related]
11. Development of a sustained-release biodegradable polymer delivery system for site-specific delivery of oligonucleotides: characterization of P(LA-GA) copolymer microspheres in vitro. Lewis KJ; Irwin WJ; Akhtar S J Drug Target; 1998; 5(4):291-302. PubMed ID: 9713978 [TBL] [Abstract][Full Text] [Related]
12. Polyethylenimine but not cationic lipid improves antisense activity of 3'-capped phosphodiester oligonucleotides. Dheur S; Dias N; van Aerschot A; Herdewijn P; Bettinger T; Rémy JS; Hélène C; Saison-Behmoaras ET Antisense Nucleic Acid Drug Dev; 1999 Dec; 9(6):515-25. PubMed ID: 10645777 [TBL] [Abstract][Full Text] [Related]
13. Polyalkylcyanoacrylate nanoparticles as polymeric carriers for antisense oligonucleotides. Chavany C; Le Doan T; Couvreur P; Puisieux F; Hélène C Pharm Res; 1992 Apr; 9(4):441-9. PubMed ID: 1495887 [TBL] [Abstract][Full Text] [Related]
14. Antisense oligonucleotide delivery with polyhexylcyanoacrylate nanoparticles as carriers. Zimmer A Methods; 1999 Jul; 18(3):286-95, 322. PubMed ID: 10454987 [TBL] [Abstract][Full Text] [Related]
15. Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides. Fattal E; Vauthier C; Aynie I; Nakada Y; Lambert G; Malvy C; Couvreur P J Control Release; 1998 Apr; 53(1-3):137-43. PubMed ID: 9741921 [TBL] [Abstract][Full Text] [Related]
16. Effect of ultrasonication on the stability of oligonucleotides adsorbed on nanoparticles and liposomes. Zobel HP; Werner D; Gilbert M; Noe CR; Stieneker F; Kreuter J; Zimmer A J Microencapsul; 1999; 16(4):501-9. PubMed ID: 10420334 [TBL] [Abstract][Full Text] [Related]
17. Mannosylated chitosan nanoparticles for delivery of antisense oligonucleotides for macrophage targeting. Asthana GS; Asthana A; Kohli DV; Vyas SP Biomed Res Int; 2014; 2014():526391. PubMed ID: 25057492 [TBL] [Abstract][Full Text] [Related]
18. Oligonucleotide structure influences the interactions between cationic polymers and oligonucleotides. Sundaram S; Viriyayuthakorn S; Roth CM Biomacromolecules; 2005; 6(6):2961-8. PubMed ID: 16283715 [TBL] [Abstract][Full Text] [Related]
19. Nanoparticle formulation enhances the delivery and activity of a vascular endothelial growth factor antisense oligonucleotide in human retinal pigment epithelial cells. Aukunuru JV; Ayalasomayajula SP; Kompella UB J Pharm Pharmacol; 2003 Sep; 55(9):1199-206. PubMed ID: 14604462 [TBL] [Abstract][Full Text] [Related]
20. Spongelike alginate nanoparticles as a new potential system for the delivery of antisense oligonucleotides. Aynié I; Vauthier C; Chacun H; Fattal E; Couvreur P Antisense Nucleic Acid Drug Dev; 1999 Jun; 9(3):301-12. PubMed ID: 10435755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]